China’s Innovative Turn and the Changing Pharmaceutical Landscape

Presenter Information

Peter K. Yu, Texas A&M Law School

Panel

Panel 10: An International Perspective

Moderator

Mark Christiansen, Associate Clinical Professor, University of the Pacific, Physician Assistant Program

Description

This presentation examines how China’s innovative turn will affect the global pharmaceutical landscape. It discusses the latest changes concerning the proposed Fourth Amendment to the Patent Law and the proposed Provisional Measures for the Implementation of Test Data Protection for Pharmaceutical Products. It also assesses China’s position on the protection of pharmaceutical and biological products in international and regional trade negotiations, such as the Regional Comprehensive Economic Partnership.

Speaker Bio

Peter K. Yu is Professor of Law, Professor of Communication and Director of the Center for Law and Intellectual Property at Texas A&M University. He previously held the Kern Family Chair in Intellectual Property Law and was the founding director of the Intellectual Property Law Center at Drake University Law School. He served as Wenlan Scholar Chair Professor at Zhongnan University of Economics and Law in Wuhan, China and a visiting professor of law at Bocconi University, Hanken School of Economics, Hokkaido University, the University of Haifa, the University of Helsinki, the University of Hong Kong, the University of Strasbourg and Washington and Lee University. He is the Director of Studies of the American Branch of the International Law Association and has served as the general editor of The WIPO Journal published by the World Intellectual Property Organization.

Location

Pacific McGeorge School of Law, Lecture Hall, 3200 Fifth Ave., Sacramento, CA

This document is currently not available here.

Share

COinS
 
Apr 6th, 11:00 AM Apr 6th, 12:00 PM

China’s Innovative Turn and the Changing Pharmaceutical Landscape

Pacific McGeorge School of Law, Lecture Hall, 3200 Fifth Ave., Sacramento, CA

This presentation examines how China’s innovative turn will affect the global pharmaceutical landscape. It discusses the latest changes concerning the proposed Fourth Amendment to the Patent Law and the proposed Provisional Measures for the Implementation of Test Data Protection for Pharmaceutical Products. It also assesses China’s position on the protection of pharmaceutical and biological products in international and regional trade negotiations, such as the Regional Comprehensive Economic Partnership.